Lars O. Hansson

1.3k total citations
22 papers, 1.0k citations indexed

About

Lars O. Hansson is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lars O. Hansson has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lars O. Hansson's work include Glutathione Transferases and Polymorphisms (8 papers), Receptor Mechanisms and Signaling (4 papers) and Cancer-related Molecular Pathways (4 papers). Lars O. Hansson is often cited by papers focused on Glutathione Transferases and Polymorphisms (8 papers), Receptor Mechanisms and Signaling (4 papers) and Cancer-related Molecular Pathways (4 papers). Lars O. Hansson collaborates with scholars based in Sweden, United Kingdom and Australia. Lars O. Hansson's co-authors include Assaf Friedler, Alan R. Fersht, Nicholas Waters, Dmitry B. Veprintsev, Arvid Carlsson, Bengt Mannervik, Stefan Rüdiger, Stefan M.V. Freund, Maria Carlsson and Mikael Widersten and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Lars O. Hansson

22 papers receiving 976 citations

Peers

Lars O. Hansson
John N.D. Wurpel United States
Francesco G. Salituro United States
Richard R. Fritz United States
Mária Staub Hungary
Vincent M. Coghlan United States
Simon E. Ward United Kingdom
Lars O. Hansson
Citations per year, relative to Lars O. Hansson Lars O. Hansson (= 1×) peers Elizabeth Donohue

Countries citing papers authored by Lars O. Hansson

Since Specialization
Citations

This map shows the geographic impact of Lars O. Hansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars O. Hansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars O. Hansson more than expected).

Fields of papers citing papers by Lars O. Hansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars O. Hansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars O. Hansson. The network helps show where Lars O. Hansson may publish in the future.

Co-authorship network of co-authors of Lars O. Hansson

This figure shows the co-authorship network connecting the top 25 collaborators of Lars O. Hansson. A scholar is included among the top collaborators of Lars O. Hansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars O. Hansson. Lars O. Hansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Friedler, Assaf, Dmitry B. Veprintsev, Lars O. Hansson, & Alan R. Fersht. (2003). Kinetic Instability of p53 Core Domain Mutants. Journal of Biological Chemistry. 278(26). 24108–24112. 119 indexed citations
3.
Friedler, Assaf, Lars O. Hansson, Dmitry B. Veprintsev, et al.. (2002). A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants. Proceedings of the National Academy of Sciences. 99(2). 937–942. 217 indexed citations
4.
Hansson, Lars O., Assaf Friedler, Stefan M.V. Freund, Stefan Rüdiger, & Alan R. Fersht. (2002). Two sequence motifs from HIF-1α bind to the DNA-binding site of p53. Proceedings of the National Academy of Sciences. 99(16). 10305–10309. 110 indexed citations
5.
Widersten, Mikael, et al.. (2000). [23] Use of phage display and transition-state analogs to select enzyme variants with altered catalytic properties: Glutathione transferase as an example. Methods in enzymology on CD-ROM/Methods in enzymology. 328. 389–404. 8 indexed citations
6.
Hansson, Lars O. & Bengt Mannervik. (2000). [28] Use of chimeras generated by DNA shuffling: Probing structure-function relationships among glutathione transferases. Methods in enzymology on CD-ROM/Methods in enzymology. 328. 463–477. 7 indexed citations
7.
Hansson, Lars O., et al.. (1999). Evolution of differential substrate specificities in Mu class glutathione transferases probed by DNA shuffling 1 1Edited by R. Huber. Journal of Molecular Biology. 287(2). 265–276. 41 indexed citations
9.
Hansson, Lars O., Mikael Widersten, & Bengt Mannervik. (1999). An approach to optimizing the active site in a glutathione transferase by evolution in vitro. Biochemical Journal. 344(1). 93–100. 19 indexed citations
10.
Hansson, Lars O., et al.. (1999). An approach to optimizing the active site in a glutathione transferase by evolution in vitro. Biochemical Journal. 344(1). 93–93. 11 indexed citations
11.
Mannervik, Bengt, Alexander D. Cameron, Lars O. Hansson, et al.. (1998). An evolutionary approach to the design of glutathione-linked enzymes. Chemico-Biological Interactions. 111-112. 15–21. 18 indexed citations
12.
Carlsson, Arvid, Lars O. Hansson, Nicholas Waters, & Maria Carlsson. (1997). Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications. Life Sciences. 61(2). 75–94. 154 indexed citations
13.
Hansson, Lars O., Mikael Widersten, & Bengt Mannervik. (1997). Mechanism-Based Phage Display Selection of Active-Site Mutants of Human Glutathione Transferase A1-1 Catalyzing SNAr Reactions. Biochemistry. 36(37). 11252–11260. 44 indexed citations
15.
Hansson, Lars O., et al.. (1995). Acute dopaminergic influence on plasma adrenaline levels in the rat. European Journal of Pharmacology. 273(3). 247–257. 20 indexed citations
16.
Waters, Nicholas, Lars O. Hansson, Lena Löfberg, & Arvid Carlsson. (1994). Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo. European Journal of Pharmacology. 251(2-3). 181–190. 13 indexed citations
17.
Sonesson, Clas, Lars O. Hansson, Nicholas Waters, et al.. (1994). substituted (S)-Phenylpiperidines and Rigid Congeners as Preferential Dopamine Autoreceptor Antagonists: Synthesis and Structure-Activity Relationships. Journal of Medicinal Chemistry. 37(17). 2735–2753. 92 indexed citations
18.
Carter, Ned, Lars O. Hansson, Bo Holmberg, & Lennart Melin. (1980). SHOPLIFTING REDUCTION THROUGH THE USE OF SPECIFIC SIGNS. Journal of Organizational Behavior Management. 2(2). 73–84. 11 indexed citations
19.
Ludvigsson, Johnny, Lars O. Hansson, & G. Tibbling. (1977). Vitamin C as a Preventive Medicine against Common Colds in Children. Scandinavian Journal of Infectious Diseases. 9(2). 91–98. 27 indexed citations
20.
Hansson, Lars O. & H. Odelram. (1965). The influence of thrombocyte aggregation on renal circulation : an experimental study in the cat. Gothenburg University Publications Electronic Archive (Gothenburg University). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026